Search

Halimeda macroloba (H. macroloba) a seaweed commonly known as green macroalgae is a potential source of bioactive compounds utilised in nutraceuticals and pharmaceuticals. However, there are no reliable scientific studies that describe harmful consequences, which attest to its safety. Thus, the current investigation focuses on a 14-day acute toxicity assessment of H. macroloba hydroalcoholic extract (HME). HME was prepared using 70 % alcohol as solvent by the maceration method for 72 h and Soxhlet method. Phytochemical analysis was done using standard procedures, according to OECD 423 guidelines. Female Wistar albino rats fasted overnight and received a single oral dosage of 50, 300, and 2,000 mg/kg BW (body weight). Further rats were starved for 4 h and watched individually for every 30 minutes, then twice a day for 14 days. To determine the toxicity overall behaviour, BW, haematological, biochemical, histopathology, and gross morphology were examined. Pharmacologically active phytoconstituents were identified by phytochemical analysis. No significant abnormalities/fatalities from single-dose of HME at escalating doses. No BW or behavioural changes. The majority of the haematological and biochemical parameters were normal. Did not show any apparent changes. simultaneously, a few indicated slight variations that may or may not be caused by HME extract no lesions or anomalies in Gross morphology. Histopathological investigations revealed that HME had no adverse effects on organs. HME administration at doses up to 2,000 mg/kg BW didn't result in acute toxicity/impairment to the pancreas, liver or kidney. Nevertheless, the study's limited test dose of 2,000 mg/kg, BW, didn't result in any fatalities/ adverse effects. [ABSTRACT FROM AUTHOR]